Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Bayer Signs A Pair Of Crop R&D Deals

by Patricia L. Short
April 27, 2009 | A version of this story appeared in Volume 87, Issue 17

Bayer CropScience and Israel's Evogene have signed a three-year pact focused on increasing rice productivity and yield. Candidate genes discovered by Evogene will be introduced into Bayer's rice research pipeline for the development of high-yielding hybrid rice. Bayer and Evogene established their first rice R&D collaboration in 2007. Meanwhile, Bayer and Belgium's Janssen Pharmaceutica are joining forces to develop new post-harvest methods of protecting produce against fungal diseases. They will draw on Bayer's portfolio of fungicide active ingredients.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.